Anzeige
Mehr »
Mittwoch, 03.06.2026 - Börsentäglich über 12.000 News
Entsteht hier die nächste Quantum-Story?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2R7AB | ISIN: XS2049769297 | Ticker-Symbol:
Frankfurt
02.06.26 | 17:17
92,59 
+0,06 % +0,06
Branche
Gesundheitswesen
Aktienmarkt
Anleihen
1-Jahres-Chart
MOLNLYCKE HOLDING AB Chart 1 Jahr
5-Tage-Chart
MOLNLYCKE HOLDING AB 5-Tage-Chart
RealtimeGeldBriefZeit
92,6292,7402.06.

Aktuelle News zur MOLNLYCKE

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MOLNLYCKE Aktie jetzt für 0€ handeln
21.05.Mölnlycke Health Care and Zhende Medical form pioneering joint venture to expand access to advanced wound care solutions in China339First-of-its-kind joint venture combines the two companies' wound care portfolios to deliver a broader wound care offering in ChinaCommercial reach spans nearly 10,000 hospitals, 200,000...
► Artikel lesen
28.04.Mölnlycke: New guidance on surgical gloving to aid hand health of surgical teams and improve clinical outcomes380New consensus statements determined by a group globally recognised clinical experts have the potential to improve clinical outcomes and support career longevity for all those on a surgical...
► Artikel lesen
27.04.Mölnlycke: Simple glove change could save the NHS £45 million over five years and improve caesarean safety471GOTHENBURG, Sweden, April 27, 2026 /PRNewswire/ -- A new study1 published in The Journal of Hospital Infection shows that introducing a simple glove change during caesarean birth could deliver...
► Artikel lesen
27.04.MOLNLYCKE: Simple glove change could save the NHS £45 million over five years and improve caesarean safety2
15.04.MOLNLYCKE: Mölnlycke Health Care announces Andreas Johansson as Interim Chief Financial Officer2
01.04.MOLNLYCKE: Mölnlycke Health Care annual report 2025 highlights sustainable growth and strategic transformation1
31.03.Mölnlycke: Europe faces a growing chronic wound crisis - time to act is now526GOTHENBURG, Sweden, March 31, 2026 /PRNewswire/ -- Mölnlycke, a global leader in MedTech, today welcomes the publication of Shaping the future of wound care in Europe, the first joint industry...
► Artikel lesen
31.03.MOLNLYCKE: Europe faces a growing chronic wound crisis - time to act is now2
24.03.MOLNLYCKE: Mölnlycke Health Care AB: CEO, Zlatko Rihter, announces resignation, Guillaume Joucla appointed interim CEO3
24.03.Investor AB: Guillaume Joucla appointed interim CEO of Mölnlycke660Guillaume Joucla has been appointed interim CEO of Mölnlycke, following Zlatko Rihter's decision to resign after more than five years as CEO. Mölnlycke's board is now initiating the recruitment of a...
► Artikel lesen
27.01.MOLNLYCKE: Mölnlycke celebrates 100 million ProcedurePak trays - advancing operating room efficiency worldwide1
05.11.25Mölnlycke Health Care: Mölnlycke establishes first wound care manufacturing site in China631CHANGSHU, China and GOTHENBURG, Sweden, Nov. 5, 2025 /PRNewswire/ -- Mölnlycke® Health Care, a global leader in MedTech, headquartered in Gothenburg, Sweden, is celebrating the commencement...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1